Pittsburgh sportstech company can now livestream your kid’s games

Seasons change, companies merge, and contracts are secured every week here in the Steel City. It can be hard to keep up with all the changes — so we keep up for you with this monthly dispatch.

Keep reading to catch up with developments you might’ve missed and learn what they mean for the region.

Diamond Kinetics gets into livestreaming youth sports

Pittsburgh-based Diamond Kinetics, which has notched wins in the form of funding raises and MLB partnerships, has acquired youth sports streamer sidelineHD. In addition to livestreaming games, the platform uses AI to create video highlights that can be shared by families and friends.

Although financial details of the acquisition weren’t disclosed, Diamond Kinetics CEO and cofounder CJ Handron said it’ll allow the 2012-founded sportstech company to provide enhanced player experiences.

“This acquisition aligns perfectly with Diamond Kinetics’ vision of providing a unified and complete experience for youth baseball and softball athletes and families,” said Handron. “By integrating sidelineHD’s live streaming and video highlights capabilities into our offering, we are now able to deliver even more value to users as they move from practice time to in-game action, and vice versa.”

Safer cars thanks to Ansys

If your next car is safer and more comfortable, you might be thanking Ansys. The Canonsburg-based company has secured a contract with Hyundai Motor Co., one of the largest auto manufacturers in the world, to provide structural analysis.

Ansys, which is in line to be acquired by California-based Synopsys in a $35 billion deal, was chosen by Hyundai after a competitive 18-month process to evaluate structural simulation solutions.

The contract illustrates its ability to meet the automotive industry’s needs and engineering challenges, said Ansys Senior Vice President Shane Emswiler, adding, “Ansys and Hyundai share an unwavering commitment to innovation and quality, and together we will usher in a new era of safe, comfortable, and reliable vehicles.”

California health system signs Abridge for AI solution

Abridge has been in the news recently for its $150 million Series C raise. The Lawrenceville-based health tech company also recently signed a big new client: UCI Health, the health system of the University of California

The company, which uses generative AI to turn doctor-patient conversations into structured clinical notes, has previously collaborated with other healthcare institutions, including Yale New Haven Health System, Emory Healthcare, the University of Kansas Health System, and UPMC.

This deployment will be focused on furthering Abridge’s mission of reducing the burden of clinical documentation for healthcare providers while making the system as a whole more efficient. “We are already seeing initial use by integrative medicine clinicians who are saving up to 40 minutes per patient,” said Abridge CEO and founder Shiv Rao.

“We are thrilled to work with UCI Health,” he added, “an institution with a deep history of innovation and leadership in healthcare.”

Imagine Pharma launches a foundation

Imagine Pharma launched a foundation to advance metabolic research with a focus on the needs of veterans.

The Oakland-based biotech company typically focuses its attention on developing therapies and treatments for diseases with fewer available medical options. Now it’s branching out to impact those living with diabetes through charitable efforts.

The Imagine Pharma Foundation plans to collaborate with research institutions, pharmaceutical companies, healthcare providers, and other nonprofit organizations to advance metabolic and diabetes research, increase access to cutting-edge treatments for veterans and communities in need, support other metabolic research-focused nonprofits and implement diabetes prevention education and awareness programs.

“I am thrilled with the opportunity to direct the work of the Imagine Pharma Foundation and to contribute to impacting the lives of those affected by diabetes,” said executive director John Paul Midolo, “especially our US veteran population, which is disproportionately impacted by this disease.”